Company profile for Cogent Biosciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Cogent Biosciences is a biotechnology company developing real solutions to treat genetically driven diseases. With a focus on the design of rational precision therapies, we are leveraging validated biology to address the true underlying drivers of disease and provide real hope for patients. Millions of people around the world are living with a genetically defined disease. Mutations can create a ripple effect in the body to tr...
Cogent Biosciences is a biotechnology company developing real solutions to treat genetically driven diseases. With a focus on the design of rational precision therapies, we are leveraging validated biology to address the true underlying drivers of disease and provide real hope for patients. Millions of people around the world are living with a genetically defined disease. Mutations can create a ripple effect in the body to trigger illness – cancers, autoimmune conditions, and rare diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
200 Cambridge Park Drive, Suite 2500 Cambridge, MA 02140
Telephone
Telephone
617.945.5576
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/06/3201063/0/en/Cogent-Biosciences-Presents-Full-SUMMIT-Results-of-Bezuclastinib-in-Patients-with-NonAdvanced-Systemic-Mastocytosis-NonAdvSM-at-the-67th-Annual-Meeting-of-the-American-Society-of-H.html

GLOBENEWSWIRE
06 Dec 2025

https://www.globenewswire.com/news-release/2025/11/14/3188255/0/en/Cogent-Biosciences-Announces-Participation-in-the-Jefferies-Global-Healthcare-Conference.html

GLOBENEWSWIRE
14 Nov 2025

https://www.fiercebiotech.com/biotech/cogent-eyes-fda-submission-cancer-asset-after-clearing-another-phase-3-hurdle

FIERCE BIOTECH
12 Nov 2025

https://www.globenewswire.com/news-release/2025/11/10/3185026/0/en/Cogent-Biosciences-Announces-Proposed-Concurrent-Public-Offerings-of-Convertible-Senior-Notes-Due-2031-and-Common-Stock.html

GLOBENEWSWIRE
10 Nov 2025

https://www.globenewswire.com/news-release/2025/11/03/3179331/0/en/Cogent-Biosciences-Announces-Multiple-Presentations-at-the-67th-Annual-American-Society-of-Hematology-ASH-Meeting.html

GLOBENEWSWIRE
03 Nov 2025

https://www.globenewswire.com/news-release/2025/11/03/3179389/0/en/Cogent-Biosciences-Reports-Recent-Business-Highlights-and-Third-Quarter-2025-Financial-Results.html

GLOBENEWSWIRE
03 Nov 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty